Search research articles
Contact Us
Filters
Showing results (311-320 of 407) with videos related to
Page
of 41
Sort By:
Journal of Gastroenterology and Hepatology
|
January 12, 2016
Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma
Anthony W H Chan, Takshi Kumada, Hidenori Toyoda, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 17, 2007
Adjuvant chemoradiation for gastric cancer: experience in the Chinese population
W K Tsang, S F Leung, S K W Chiu, et al.
Nature Reviews. Clinical Oncology
|
July 1, 2021
Nasopharyngeal carcinoma: an evolving paradigm
Kenneth C W Wong, Edwin P Hui, Kwok-Wai Lo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 25, 2009
Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphisms
B B Y Ma, E P Hui, S C C Wong, et al.
Investigational New Drugs
|
September 17, 2009
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Brigette B Y Ma, Vivian W Y Lui, Fan Fong Poon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2004
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy
Winnie Yeo, Paul K S Chan, Wing M Ho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2004
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
W Yeo, K C Lam, B Zee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2018
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study
Edwin P Hui, Brigette B Y Ma, Herbert H F Loong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2002
Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival
Edwin P Hui, Anthony T C Chan, Francesco Pezzella, et al.
Molecular Cancer Research : MCR
|
November 5, 2013
The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation
Gigi C G Choi, Jisheng Li, Yajun Wang, et al.
Page
of 41
Search research articles
Search
Showing results (311-320 of 407) with videos related to
Sort By:
Page
of 41
Journal of Gastroenterology and Hepatology
|
January 12, 2016
Integration of albumin-bilirubin (ALBI) score into Barcelona Clinic Liver Cancer (BCLC) system for hepatocellular carcinoma
Anthony W H Chan, Takshi Kumada, Hidenori Toyoda, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 17, 2007
Adjuvant chemoradiation for gastric cancer: experience in the Chinese population
W K Tsang, S F Leung, S K W Chiu, et al.
Nature Reviews. Clinical Oncology
|
July 1, 2021
Nasopharyngeal carcinoma: an evolving paradigm
Kenneth C W Wong, Edwin P Hui, Kwok-Wai Lo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 25, 2009
Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphisms
B B Y Ma, E P Hui, S C C Wong, et al.
Investigational New Drugs
|
September 17, 2009
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Brigette B Y Ma, Vivian W Y Lui, Fan Fong Poon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 3, 2004
Lamivudine for the prevention of hepatitis B virus reactivation in hepatitis B s-antigen seropositive cancer patients undergoing cytotoxic chemotherapy
Winnie Yeo, Paul K S Chan, Wing M Ho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2004
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy
W Yeo, K C Lam, B Zee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 6, 2018
Efficacy, Safety, and Pharmacokinetics of Axitinib in Nasopharyngeal Carcinoma: A Preclinical and Phase II Correlative Study
Edwin P Hui, Brigette B Y Ma, Herbert H F Loong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 13, 2002
Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival
Edwin P Hui, Anthony T C Chan, Francesco Pezzella, et al.
Molecular Cancer Research : MCR
|
November 5, 2013
The metalloprotease ADAMTS8 displays antitumor properties through antagonizing EGFR-MEK-ERK signaling and is silenced in carcinomas by CpG methylation
Gigi C G Choi, Jisheng Li, Yajun Wang, et al.
Page
of 41